The incidence of obesity has been rapidly increasing in the United States and other developed countries. Our hypothesis is that changes are occurring in the indigenous microbial populations that are of ancient origin, due to modernization including antibiotic exposure. Our hypothesis is that these changes in the composition of the microbiome are at least in part playing a role in the increasing incidence of obesity. More specifically, we also hypothesize that common antibiotic treatments are incidentally causing changes in the composition of metabolically active gastrointestinal bacterial populations, and that the effects may be sequential in which maternal changes are then inherited by the next generation. We will test this hypothesis by studying both the colonic microbiota, and Helicobacter pylori, the dominant gastric bacteria that interact with gastric epithelium, which produces hormones (leptin and ghrelin) that are involved in energy homeostasis. We propose 5 studies. Study A1 will be to assess the association of maternal H. pylori status on the development of childhood obesity in a presently enrolled cohort in The Netherlands. Study A2 will examine the relationship in children of H. pylori status and the physiology of gastric hormones, inflammation, and immunity. Study A3 will assess the changes in hormonal and metabolic phenotypes in young adults due to clinically indicated eradication of H. pylori. Study B1 will assess the effects on young mice of the continuous administration of low antibiotic doses in terms of metabolic and hormonal phenotypes. Study B2 will examine the development of the intestinal microbiota over the first year of life in singletons and twins, and will assess the effects of antibiotic perturbation on the developmental process. In total, these studies will examine the relationship changing gastric and colonic bacterial population composition with metabolic phenotypes, and provide opportunities for further exploration.
The incidence of obesity is rapidly increasing in the United States and other developed countries. We will explore the hypothesis that changes in the composition and activity of the ancient endogenous microbiota of the gastrointestinal tract is playing a role in the development of obesity. We will focus on both maternal and antibiotic effects on the composition of the gastric and colonic bacterial populations, and their metabolic effects.
|Cox, Laura M; Yamanishi, Shingo; Sohn, Jiho et al. (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158:705-21|
|Segal, Leopoldo N; Blaser, Martin J (2014) A brave new world: the lung microbiota in an era of change. Ann Am Thorac Soc 11 Suppl 1:S21-7|
|Blaser, Martin J (2014) The microbiome revolution. J Clin Invest 124:4162-5|
|Blaser, Martin J; Dominguez-Bello, Maria G; Contreras, Monica et al. (2013) Distinct cutaneous bacterial assemblages in a sampling of South American Amerindians and US residents. ISME J 7:85-95|
|Cox, Laura M; Blaser, Martin J (2013) Pathways in microbe-induced obesity. Cell Metab 17:883-94|
|Chen, Yu; Segers, Stephanie; Blaser, Martin J (2013) Association between Helicobacter pylori and mortality in the NHANES III study. Gut 62:1262-9|
|den Hollander, Wouter J; Holster, I Lisanne; den Hoed, Caroline M et al. (2013) Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city. J Gastroenterol Hepatol 28:1705-11|
|Blustein, J; Attina, T; Liu, M et al. (2013) Association of caesarean delivery with child adiposity from age 6 weeks to 15 years. Int J Obes (Lond) 37:900-6|
|Huong, Duong Thu; Zhao, Yanan; Nguyet, Nguyen Thi et al. (2013) Candida krusei colonization in patients with gastrointestinal diseases. Med Mycol 51:884-7|
|Marild, Karl; Ye, Weimin; Lebwohl, Benjamin et al. (2013) Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol 13:109|
Showing the most recent 10 out of 18 publications